Big Gain For Cyclerion Therapeutics, Inc.

Fri, Jun 14, 2024 at 07:17 PM
Big Gain For Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) soared at $2.72, representing a gain of 32.5%. On Fri, Jun 14, 2024, CYCN:NASDAQ touched a New 2-Week Intraday High of $2.97. From Fri, May 31, 2024, the stock recorded 33.33% Up Days and 20.00% Green Days

About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.